Skip to main content

Argenx SE

ARGX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001697862

No open-market purchases or sales by Argenx SE insiders were filed in the last 90 days; 510 institutions reported holding it in 13F filings for Q2 2026, worth $26.1B in total; no superinvestor holds it.

Holders of 5% or more of ARGX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Argenx SE, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of ARGX
HolderLatest formStakeChangeFirst filedLatest filingFiling
FMR LLC13G/A8.70%5.41M shares−1.30 ppfrom 10.00%Feb 8, 20217 filingsMay 6, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

22 Schedule 13D and 13G filings on Argenx SE, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on ARGX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 14, 202610:38 AM ETPrice T Rowe Associates Inc13G/A4.30%2.68M shares−1.70 ppfrom 6.00%Below 5%Jun 30, 2026SEC
May 6, 202611:00 AM ETFMR LLCand 1 other13G/A8.70%5.41M shares−1.30 ppfrom 10.00%Mar 31, 2026SEC
Nov 14, 202512:19 PM ETPrice T Rowe Associates Inc13G/A6.00%3.65M shares−2.20 ppfrom 8.20%Sep 30, 2025SEC
Aug 14, 20251:07 PM ETPrice T Rowe Associates Inc13G/A8.20%4.98M shares–Jun 30, 2025SEC
Aug 12, 20256:14 AM ETArtisan Partners Limited Partnershipand 3 others13G/A3.80%2.35M shares–Below 5%Jun 30, 2025SEC
Feb 12, 20259:16 AM ETFMR LLCand 1 other13G/A10.00%6.02M shares–Dec 31, 2024SEC
Feb 14, 2024Price T Rowe Associates Inc13G/AOld format–––SEC
Feb 12, 2024Artisan Partners Limited Partnership13GOld format–––SEC
Feb 9, 2024FMR LLC13G/AOld format–––SEC
Feb 1, 20241:04 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 14, 2023Price T Rowe Associates Inc13G/AOld format–––SEC
Feb 10, 2023Artisan Partners Limited Partnership13G/AOld format–––SEC
Feb 9, 2023FMR LLC13G/AOld format–––SEC
Feb 1, 20234:54 PM ETBlackRock Inc.13G/AOld format–––SEC
Mar 11, 20222:13 PM ETBlackRock Inc.13GOld format–––SEC
Feb 14, 2022Price T Rowe Associates Inc13G/AOld format–––SEC
Feb 9, 2022FMR LLC13G/AOld format–––SEC
Feb 8, 20225:05 PM ETBlackRock Inc.13GOld format–New–SEC
Feb 4, 2022Artisan Partners Limited Partnership13GOld format–New–SEC
Feb 16, 2021Price T Rowe Associates Inc13G/AOld format–––SEC
Feb 10, 2021FMR LLC13G/AOld format–––SEC
Feb 8, 2021FMR LLC13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Argenx SE shares.

No Form 144 notices for Argenx SE are on file.